Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E.V.
Bonn, NRW Doing business as Dzne E.V.
- UEI
- LGCNJ34764N3
- CAGE
- CF608
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- SAM.gov registration date
- Physical address
- Venusberg Campus 1, 53127 Bonn, Germany
- Website
- dzne.de
- Founded
- 2009
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Trustees Of Boston University | R01AG084624 | $126,217 | |
| The Washington University | U19AG032438 | $0 | |
| Trustees Of Boston University | RF1AG078299 | $177,748 |
Latest 3 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Arc | Amsterdam, NH | 813920 Professional Organizations |
| Brain Matters Research LLC | Delray Beach, FL | — |
| Institut De Recerca De L'hospital De La Santa Creu I Sant PAU | Barcelona, CT | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Neurodex Inc. | Natick, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Fundacio De Recerca Clinic Barcelona-Institut D’investigacions Biomediques August Pi I Sunyer | Barcelona, CT | 813212 Voluntary Health Organizations |
About the company
Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E.V. (DZNE) is a non-profit research institute focused on studying neurodegenerative diseases. According to its website, DZNE aims to understand the causes and risk factors for neurodegeneration and to develop new therapeutic and healthcare strategies.
DZNE has received federal grant funding as both a prime recipient and subrecipient to conduct research related to neurodegenerative diseases like Alzheimer's. As a subrecipient, DZNE has provided research services to measure and analyze cerebrospinal fluid and blood plasma biomarkers linked to Alzheimer's disease progression under a subaward from Washington University. This research analyzed samples and data collected through the Dominantly Inherited Alzheimer Network (DIAN) observational study and DIAN-TU therapeutic trial. DZNE has also received subawards to relate plasma tau levels to markers of neurodegeneration and clinical progression in Alzheimer's patients. As a prime recipient, DZNE conducts research on microglial activation in Alzheimer's through analysis of cerebrospinal fluid samples from the DIAN longitudinal cohort. Through both prime and sub federal awards, DZNE provides neurodegenerative disease research services involving biofluid analysis, biomarker measurement, and data analysis.
Quick answers
Is Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E.V. registered in SAM.gov?
Yes. Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E.V.'s SAM.gov registration is active through June 15, 2027.
On GovTribe
See Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E.V.'s full federal record
- Similar vendors